RSS-Feed abonnieren

DOI: 10.1055/s-0041-1726170
Inhibitory Effects of Alendronate on Adhesion and Viability of Preosteoblast Cells on Titanium Discs
Funding The funding for this study was granted by Thammasat University Research Fund under the TU Research Scholar award id. 77/2561.

Abstract
Objective This study aimed to investigate the effects of alendronate (ALN; a bisphosphonate) on adhesion and viability of preosteoblasts using different cell passages on sandblasted and acid-etched (SLA) Ti surfaces.
Materials and Methods Preosteoblast, MC3T3, cells (passage 42; P42 and passage 62; P62) were cultured with ALN (1 and 5 µM) on cell culture plate for 7 days. Cells were lifted, counted, and seeded on SLA Ti surfaces. Cells were incubated on the discs for 6 hours to examine cell adhesion by using confocal microscopy and for 24 hours to determine cell viability by using MTT assay.
Results ALN interfered with cell adhesion on Ti surfaces by reducing the cell number in both cell passages. Nuclei of untreated cells showed oval shape, whereas some nuclei of ALN-treated cells demonstrated crescent and condensed appearance. ALN at 1 and 5 µM significantly decreased nuclear area and perimeter in P42, while ALN at 5 µM reduced nuclear area and perimeter in P62. After 24 hours, cells (P42) grown on Ti surfaces showed decreased cell viability when culturing with 5 µM ALN.
Conclusion ALN reduced cell adhesion and viability of preosteoblasts on Ti surfaces. ALN treatment seemed to exert higher inhibitory effects on nuclear shape and size as well as cell viability in lower cell passage. This led to the reduction in cell to implant surface interaction after encountering bisphosphonate treatment.
Publikationsverlauf
Artikel online veröffentlicht:
07. Juni 2021
© 2021. European Journal of Dentistry. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Ruggiero SL, Dodson TB, Fantasia J. et al. American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg 2014; 72 (10) 1938-1956
- 2 Holzinger D, Seemann R, Matoni N, Ewers R, Millesi W, Wutzl A. Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 2014; 72 (10) 1937.e1-1937.e8
- 3 Kasai T, Pogrel MA, Hossaini M. The prognosis for dental implants placed in patients taking oral bisphosphonates. J Calif Dent Assoc 2009; 37 (01) 39-42
- 4 Chrcanovic BR, Albrektsson T, Wennerberg A. Bisphosphonates and dental implants: a meta-analysis. Quintessence Int 2016; 47 (04) 329-342
- 5 Ata-Ali J, Ata-Ali F, Peñarrocha-Oltra D, Galindo-Moreno P. What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis. Clin Oral Implants Res 2016; 27 (02) e38-e46
- 6 Koka S, Babu NM, Norell A. Survival of dental implants in post-menopausal bisphosphonate users. J Prosthodont Res 2010; 54 (03) 108-111
- 7 Gelazius R, Poskevicius L, Sakavicius D, Grimuta V, Juodzbalys G. Dental implant placement in patients on bisphosphonate therapy: a systematic review. J Oral Maxillofac Res 2018; 9 (03) e2
- 8 Zahid TM, Wang BY, Cohen RE. Influence of bisphosphonates on alveolar bone loss around osseointegrated implants. J Oral Implantol 2011; 37 (03) 335-346
- 9 Idris AI, Rojas J, Greig IR, Van’t Hof RJ, Ralston SH. Amino-bisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro. Calcif Tissue Int 2008; 82 (03) 191-201
- 10 Patntirapong S, Singhatanadgit W, Arphavasin S. Alendronate-induced atypical bone fracture: evidence that the drug inhibits osteogenesis. J Clin Pharm Ther 2014; 39 (04) 349-353
- 11 Patntirapong S, Singhatanadgit W, Chanruangvanit C, Lava-nrattanakul K, Satravaha Y. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition. J Oral Pathol Med 2012; 41 (09) 713-720
- 12 von Wilmowsky C, Moest T, Nkenke E, Stelzle F, Schlegel KA. Implants in bone: part I. A current overview about tissue response, surface modifications and future perspectives. Oral Maxillofac Surg 2014; 18 (03) 243-257
- 13 Basso FG, Pansani TN, Soares DG. Cardoso LM, Hebling J, de Souza Costa CA. Influence of bisphosphonates on the adherence and metabolism of epithelial cells and gingival fibroblasts to titanium surfaces. Clin Oral Investig 2018; 22 (02) 893-900
- 14 Vajrabhaya LO, Korsuwannawong S, Surarit R. Cytotoxic and the proliferative effect of cuttlefish bone on MC3T3-E1 osteoblast cell line. Eur J Dent 2017; 11 (04) 503-507
- 15 Peterson WJ, Tachiki KH, Yamaguchi DT. Serial passage of MC3T3-E1 cells down-regulates proliferation during osteogenesis in vitro. Cell Prolif 2004; 37 (05) 325-336
- 16 Chung CY, Iida-Klein A, Wyatt LE. et al. Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2. Biochem Biophys Res Commun 1999; 265 (01) 246-251
- 17 Taira Y, Egoshi T, Kamada K, Sawase T. Surface modification with alumina blasting and H2SO4-HCl etching for bonding two resin-composite veneers to titanium. Eur J Oral Sci 2014; 122 (01) 84-88
- 18 Scheper MA, Badros A, Salama AR. et al. A novel bioassay model to determine clinically significant bisphosphonate levels. Support Care Cancer 2009; 17 (12) 1553-1557
- 19 Colucci S, Minielli V, Zambonin G. et al. Alendronate reduces adhesion of human osteoclast-like cells to bone and bone protein-coated surfaces. Calcif Tissue Int 1998; 63 (03) 230-235
- 20 Im GI, Qureshi SA, Kenney J, Rubash HE, Shanbhag AS. Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004; 25 (18) 4105-4115
- 21 Xiong Y, Yang HJ, Feng J, Shi ZL, Wu LD. Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells. J Int Med Res 2009; 37 (02) 407-416
- 22 Ziegler U, Groscurth P. Morphological features of cell death. News Physiol Sci 2004; 19: 124-128
- 23 Mandelkow R, Gümbel D, Ahrend H. et al. Detection and quantification of nuclear morphology changes in apoptotic cells by fluorescence microscopy and subsequent analysis of visualized fluorescent signals. Anticancer Res 2017; 37 (05) 2239-2244
- 24 Filippi-Chiela EC, Oliveira MM, Jurkovski B, Callegari-Jacques SM, da Silva VD, Lenz G. Nuclear morphometric analysis (NMA): screening of senescence, apoptosis and nuclear irregularities. PLoS One 2012; 7 (08) e42522
- 25 Kwist K, Bridges WC, Burg KJ. The effect of cell passage number on osteogenic and adipogenic characteristics of D1 cells. Cytotechnology 2016; 68 (04) 1661-1667
- 26 Kassem M, Ankersen L, Eriksen EF, Clark BF, Rattan SI. Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts. Osteoporos Int 1997; 7 (06) 514-524
- 27 Thompson K, Rogers MJ, Coxon FP, Crockett JC. Cytosolic entry of bisphosphonate drugs requires acidification of vesicles after fluid-phase endocytosis. Mol Pharmacol 2006; 69 (05) 1624-1632
- 28 Foroozandeh P, Aziz AA, Mahmoudi M. Effect of cell age on uptake and toxicity of nanoparticles: the overlooked factor at the nanobio interface. ACS Appl Mater Interfaces 2019; 11 (43) 39672-39687
- 29 de-Freitas NR, Lima LB, de-Moura MB, Veloso-Guedes CC, Simamoto-Júnior PC, de-Magalhães D. Bisphosphonate treatment and dental implants: a systematic review. Med Oral Patol Oral Cir Bucal 2016; 21 (05) e644-e651